BIOTECH (159) Avenzo Therapeutics: Turning Point Therapeutics Reunion – Acquisition of Early-Stage Oncology Small Molecules, ADCs from Chinese Biotech & US Biopharma March 27, 2024March 27, 2024
BIOTECH (158) Praxis Precision Medicines: CNS Small Molecules & Antisense Oligonucleotides Platform March 27, 2024March 27, 2024
BIOTECH (157) Dr. Josep Bassaganya-Riera’s LANCL-Targeting Autoimmune Drug Discovery – from Landos Biopharma to NImmune Biopharma March 27, 2024March 27, 2024
BIOTECH (155) Stoke Therapeutics: Splicing Up-regulation by Antisense Oligonucleotides March 26, 2024March 26, 2024
BIOTECH (154) Cardior Pharmaceuticals: micro RNA Oligonucleotides Targeting Cardiology March 25, 2024March 25, 2024